Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1999
08/05/1999WO1999038498A1 Method for treating alzheimer's disease
08/05/1999WO1999038497A2 Ophthalmic composition
08/05/1999WO1999038492A1 Nasal solutions
08/05/1999WO1999038487A1 Opalescent cosmetic compositions and methods for their preparation
08/05/1999WO1999038484A1 Anti-enzyme compositions comprising ethylenediamine disuccinic acid
08/05/1999WO1999038480A2 Antiplaque oral composition and method
08/05/1999WO1999038478A1 Personal care composition containing a homogeneous terpolymer of an n-vinyl lactam and a polysiloxane
08/05/1999WO1999038467A1 Treatment of female sexual dysfunction
08/05/1999WO1999038380A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
08/05/1999WO1999024559A3 Nuclear targeting by means of streptococcal protein h
08/05/1999WO1999024398A3 Urea derivatives and their use as integrin inhibitors
08/05/1999WO1999023092A3 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
08/05/1999WO1999022722A3 Use of macrolides for the treatment of cancer and macular degeneration
08/05/1999WO1999022721A3 Unsubstituted polydiallylamine for treating hypercholesterolemia
08/05/1999WO1999021860B1 Phenanthroline derivatives
08/05/1999WO1999021541A3 Amelioration of ischemic damage using synthetic oxygen carriers
08/05/1999WO1999021538A3 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
08/05/1999WO1999020643A9 Using polyamide nucleic acid oligomers to engender a biological response
08/05/1999WO1999018959A9 Pharmaceutical formulation comprising glycine as a stabilizer
08/05/1999WO1999015542A3 Linker nucleoside, and production and use of the same
08/05/1999WO1999014226A3 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
08/05/1999WO1999011256A8 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
08/05/1999WO1999011250A3 Noribogaine in the treatment of pain and drug addiction
08/05/1999WO1999000128A9 Antithrombotic agents
08/05/1999WO1997010824A8 Use of 5ht1b receptor antagonist for the treatment of vascular disease
08/05/1999WO1997003664A8 Use of ipriflavone to reduce the number of cd8+ cells
08/05/1999DE19804376A1 Lipidmischungen sowie deren Verwendung Lipid mixtures and their use
08/05/1999DE19804251A1 Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Biphenylsulfonylcyanamide, processes for their preparation and their use as a medicament
08/05/1999CA2819705A1 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999CA2755452A1 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999CA2335037A1 Aqueous compositions comprising complexing agents and uses thereof
08/05/1999CA2322289A1 Treatment of female sexual dysfunction
08/05/1999CA2320963A1 R-lansoprazole compositions and methods
08/05/1999CA2320902A1 S-lansoprazole compositions and methods
08/05/1999CA2319833A1 Glycosidation of 4,5-epoxymorphinan-6-ols
08/05/1999CA2319781A1 Cyclic amine modulators of chemokine receptor activity
08/05/1999CA2319753A1 Antiplaque oral composition and method
08/05/1999CA2319710A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
08/05/1999CA2319649A1 Preventives or remedies for vision disorders
08/05/1999CA2319629A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999CA2319627A1 Therapeutic compounds
08/05/1999CA2319465A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
08/05/1999CA2319387A1 Neurotrophic factor secretion promoters
08/05/1999CA2319202A1 Preparation for treatment of erectile dysfunction
08/05/1999CA2319195A1 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999CA2319087A1 Methods and apparatus for accelerated orthokeratology
08/05/1999CA2318960A1 Pharmaceutical uses of optically pure (+)-bupropion
08/05/1999CA2318921A1 Pharmacological uses of optically pure (+)-bupropion
08/05/1999CA2318920A1 Pharmaceutical uses of optically pure (-)-bupropion
08/05/1999CA2318833A1 The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
08/05/1999CA2318830A1 Derivatives of 1,3,4-oxadiazolone
08/05/1999CA2318817A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999CA2318814A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999CA2318780A1 Anti-enzyme compositions comprising ethylenediamine disuccinic acid
08/05/1999CA2318738A1 Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
08/05/1999CA2318584A1 Neurotrophic properties of ipgs and ipg analogues
08/05/1999CA2318516A1 Ophthalmic composition
08/05/1999CA2318443A1 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
08/05/1999CA2318343A1 Benzo[b]pyran derivatives useful as external agents for the skin
08/05/1999CA2318336A1 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999CA2318278A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
08/05/1999CA2318215A1 Platelet aggregation inhibition using low molecular weight heparin in combination with a gp iib/iiia antagonist
08/05/1999CA2317515A1 Oxazole derivatives as serotonin-1a receptor agonists
08/05/1999CA2317459A1 Methods of identifying modulators of kinases responsive to stress
08/05/1999CA2316223A1 Hydrophilic coating for an intracorporeal medical device
08/05/1999CA2313226A1 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
08/05/1999CA2282645A1 Opalescent cosmetic compositions and methods for their preparation
08/04/1999EP0933373A1 Terpenoid lactone compounds and their production process
08/04/1999EP0933372A1 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
08/04/1999EP0933367A1 Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists
08/04/1999EP0933366A1 5-phenyl-3-pyridazinone derivatives and drug compositions containing the same
08/04/1999EP0933363A1 Parasiticidal pyrazoles
08/04/1999EP0933354A1 Calcium receptor-active compounds
08/04/1999EP0933351A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0933350A1 Tricyclic retinoids, methods for their production and use
08/04/1999EP0933346A1 NOVEL p-TERPHENYL COMPOUNDS
08/04/1999EP0933332A1 Electrolysis of water resulting in the reduction of fat content in the human liver
08/04/1999EP0933081A1 Pharmaceutical compositions containing mupirocin
08/04/1999EP0933080A1 Remedy or preventive for hyperlipemia
08/04/1999EP0933027A1 Methods and compositions for protecting animals and humans against attack and infestation by arthropod and helminth parasites
08/04/1999EP0933026A1 Compounds for protecting animals and humans against attack and infestation by arthropod parasites
08/04/1999EP0932686A2 Telomerase reverse transcriptase
08/04/1999EP0932678A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
08/04/1999EP0932613A1 BLOCKING EXPRESSION OF VIRULENCE FACTORS IN $i(S. AUREUS)
08/04/1999EP0932609A1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO 2,3-e]INDOL-8-ONE
08/04/1999EP0932606A1 Inhibitors of prenyl transferases
08/04/1999EP0932600A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1$g(b) CONVERTING ENZYME INHIBITORS
08/04/1999EP0932598A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
08/04/1999EP0932597A1 Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
08/04/1999EP0932420A1 Drug delivery using terminal complement components
08/04/1999EP0932416A2 Method and potentiated composition for treating migraine
08/04/1999EP0932411A1 Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
08/04/1999EP0932409A1 A method for producing an extract from valeriana officinalis containing high levels of valerenic acid
08/04/1999EP0932408A1 Pharmaceutical and cosmetic formulations with antimicrobial activity
08/04/1999EP0932407A1 Method for treating migraine pain
08/04/1999EP0932406A1 Methods of treating or preventing interstitial cystitis
08/04/1999EP0932405A1 Il-8 receptor antagonists
08/04/1999EP0932404A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
08/04/1999EP0932403A1 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
08/04/1999EP0932402A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
1 ... 6464 6465 6466 6467 6468 6469 6470 6471 6472 6473 6474 6475 6476 6477 6478 6479 6480 6481 6482 6483 6484 ... 7860